Both YBX3 and lncRNA HEIH regulate the therapeutic response through certain common molecular mechanisms, but the role of the tumor regulation system composed of lncRNA-HEIH/YBX3 in the tumor microenvironment (TME) of diverse tumors, especially in colon cancer, has not been fully investigated. Here, HEIH is linked to malignant colon neoplasm.